Singapore: ProBioGen, a German contract development and manufacturing organization, has developed and implemented the Pa...
Singapore: ScinoPharm will invest NT$1.13 billion (approximately $37.6 million) in the construction of a high potency cy...
Is Targeted Protein Degradation Biotech's Next Big Bet?
